Bodenstedt Matthias 4
4 · MoonLake Immunotherapeutics · Filed Mar 3, 2025
Insider Transaction Report
Form 4
Bodenstedt Matthias
Chief Financial Officer
Transactions
- Award
Class A ordinary shares, par value $0.0001 per share
2025-02-27+95,763→ 616,666 total
Footnotes (1)
- [F1]Represents shares of restricted stock that vest in four equal annual installments on February 27, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.